Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.03%
- Poor long term growth as Net Sales has grown by an annual rate of 16.97% and Operating profit at 3.37% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
Flat results in Sep 26
With ROE of 0.7, it has a Very Expensive valuation with a 1 Price to Book Value
Stock DNA
Software Products
INR 12 Cr (Micro Cap)
141.00
21
0.00%
-0.01
0.70%
0.89
Total Returns (Price + Dividend) 
Hit Kit Global for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Hit Kit Global Solutions Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals
Hit Kit Global Solutions Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 5 October 2026, reflecting a complex interplay of technical improvements overshadowed by deteriorating fundamental and valuation metrics. Despite a recent sideways technical trend and impressive stock returns, the company’s weak financial performance and expensive valuation have raised concerns among investors.
Read More
Hit Kit Global Solutions Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges
Hit Kit Global Solutions Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The software products company’s recent performance and valuation metrics present a mixed picture, with technical trends improving while financial and quality parameters remain subdued.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSEPlease find the attached Newspaper Publication for approval of Un-Audited Financial Results of the company for the second quarter and half year ended 30th September 2026
Results For The Second Quarter Ended 30Th September 2026
13-Nov-2026 | Source : BSEPlease find the attached Outcome of Board Meeting
Board Meeting Outcome for Meeting Held On 13Th November 2026 For Approval Of Q2 Results
13-Nov-2026 | Source : BSEPlease find the attached Outcome of Board Meeting
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
None
N Eswara Rao (10.81%)
78.51%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 0.00% vs 5.41% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -50.00% vs -60.00% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -18.37% vs 276.92% in Sep 2024
Growth in half year ended Sep 2025 is -93.88% vs 426.67% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -5.71% vs 250.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -92.45% vs 453.33% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 22.62% vs 211.11% in Mar 2025
YoY Growth in year ended Mar 2026 is -96.47% vs 193.75% in Mar 2025